Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2025)

Cabaletta Bio's (CABA) quarterly Interest & Investment Income came in at $1.3 million in Q4 2025, down 31.9% year-on-year from $1.9 million in Q4 2024, and down 26.66% quarter-over-quarter from $1.8 million in Q3 2025.

Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2025) Analysis & Trends

Cabaletta Bio's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.3 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 31.9% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $6.0 million, a 39.84% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, down 39.84% from the prior year.
  • Interest & Investment Income declined to $1.3 million in Q4 2025 per CABA's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $3.0 million in Q1 2024 and bottomed at $3000.0 in Q3 2021.
  • The 5-year median for Interest & Investment Income is $1.4 million (2023), against an average of $1.2 million.
  • Across the five-year window, Interest & Investment Income plunged 97.56% in 2021 and surged 12100.0% in 2022, its largest moves.
  • Year by year, Interest & Investment Income stood at $5000.0 in 2021, then jumped by 12100.0% to $610000.0 in 2022, then surged by 270.49% to $2.3 million in 2023, then dropped by 13.85% to $1.9 million in 2024, then plunged by 31.9% to $1.3 million in 2025.
  • Per Business Quant, the three latest CABA Interest & Investment Income figures stand at $1.3 million (Q4 2025), $1.8 million (Q3 2025), and $1.4 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Cabaletta Bio 184.38 Mn 184.38 Mn - 1.33 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.81 Mn
Jun 30, 2025 1.41 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 1.95 Mn
Sep 30, 2024 2.42 Mn
Jun 30, 2024 2.68 Mn
Mar 31, 2024 2.98 Mn
Dec 31, 2023 2.26 Mn
Sep 30, 2023 2.22 Mn
Jun 30, 2023 1.40 Mn
Mar 31, 2023 1.10 Mn
Dec 31, 2022 610,000.00
Sep 30, 2022 351,000.00
Jun 30, 2022 150,000.00
Mar 31, 2022 53,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 3,000.00
Jun 30, 2021 6,000.00
Mar 31, 2021 10,000.00